Philipp Karschnia

Interactive effects of clinical, molecular, and surgical factors on postoperative outcome in newly diagnosed glioblastoma: development and validation of a clinical risk score

Structural network analysis in patients with IDH-mutant gliomas grade 2 and 3

Clinical and molecular predictors for outcome in IDH-mutant gliomas WHO grade 2 and 3 diagnosed per WHO 2021 classification: effects of delayed time to diagnosis and treatment

Lymph node metastasis of an IDH-mutant astrocytoma grade 4: case report and systematic review of the pertinent literature

Clinical and neuropathological markers for distinguishing between IDH-mutant astrocytomas of WHO grade 2 and 3

Interactive effects of clinical, molecular, and surgical factors on postoperative outcome in newly diagnosed glioblastoma: development and validation of a clinical risk score

Patient age is related to favorable association of supramaximal resection with outcome in glioblastoma

A head-to-head comparison between MR- and FET PET-based delineation of residual tumor tissue in glioblastoma